Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial

BACKGROUND: Long-term oxygen therapy (LTOT) is the only component of the management of chronic obstructive pulmonary disease (COPD) that improves survival in patients with severe daytime hypoxemia. LTOT is usually provided by a stationary oxygen concentrator and is recommended to be used for at leas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacasse, Yves, Bernard, Sarah, Sériès, Frédéric, Nguyen, Van Hung, Bourbeau, Jean, Aaron, Shawn, Maltais, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223547/
https://www.ncbi.nlm.nih.gov/pubmed/28069009
http://dx.doi.org/10.1186/s12890-016-0343-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223547/
https://www.ncbi.nlm.nih.gov/pubmed/28069009
http://dx.doi.org/10.1186/s12890-016-0343-9

Ejemplares similares